1,444
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Attenuation of cyclophosphamide-induced pulmonary toxicity in Swiss albino mice by naphthalimide-based organoselenium compound 2-(5-selenocyanatopentyl)-benzo[de]isoquinoline 1,3-dione

, , , &
Pages 524-532 | Received 11 Apr 2014, Accepted 27 May 2014, Published online: 04 Dec 2014

References

  • Alarcon RA. (1976). Studies on the in vivo formation of acrolein: 3-Hydroxypropylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation. Cancer Treat Rep 60:327–35
  • Arumugam N, Sivakumar V, Thanislass J, Devaraj H. (1997). Effects of acrolein on rat liver antioxidant defense system. Indian J Exp Biol 35:1373–4
  • Brigelius-Flohé R. (1999). Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med 27:951–65
  • Chaudhary NI, Schnapp A, Park JE. (2006). Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med 173:769–76
  • Coşkun S, Gönül B, Ozer C, et al. (2007). The effects of dexfenfluramine administration on brain serotonin immunoreactivity and lipid peroxidation in mice. Cell Biol Toxicol 23:75–82
  • Das RK, Ghosh S, Sengupta A, et al. (2004). Inhibition of DMBA/croton oil-induced two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate. Eur J Cancer Prev 13:411–17
  • Das RK, Hossain SK, Bhattacharya S. (2005). Diphenylmethyl selenocyanate inhibits DMBA-croton oil induced two-stage mouse skin carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation. Cancer Lett 230:90–101
  • Davies KJ. (1993). Protein modification by oxidants and the role of proteolytic enzymes. Biochem Soc Trans 21:346–53
  • DeLeve LD. (1996). Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation. Hepatology 24:830–7
  • Fadillioğlu E, Erdoğan H. (2003). Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacol Res 47:317–22
  • Fiala ES, Sohn OS, Li H, et al. (1997). Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate. Carcinogenesis 18:1809–15
  • Förstermann U, Schmidt HH, Pollock JS, et al. (1991). Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42:1849–57
  • Fouladi M, Stempak D, Gammon J, et al. (2001). Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma. Cancer 92:914–23
  • Gharib MI, Burnett AK. (2002). Chemotherapy-induced cardiotoxicity: Current practice and prospects of prophylaxis. Eur J Heart Fail 4:235–42
  • Goldberg MA, Antin JH, Guinan EC, Rappeport JM. (1986). Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor. Blood 68:1114–18
  • Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–8
  • Gurujeyalakshmi G, Wang Y, Giri SN. (2000). Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin. Nitric Oxide 4:399–11
  • Habig WH, Pabst MJ, Jacoby WB. (1974). Glutathione S-transferases, the first enzymatic step in marcapturic acid formation. J Biol Chem 249:7130–9
  • Hossain SU, Sengupta S, Bhattacharya S. (2005). Synthesis and evaluation of antioxidative properties of a series of organoselenium compounds. Bioorg Med Chem 13:5750–8
  • Kawanishi M, Matsuda T, Nakayama A, et al. (1998). Molecular analysis of mutations induced by acrolein in human fibroblast cells using supF shuttle vector plasmids. Mutat Res 417:65–73
  • Kaya H, Oral B, Ozgüner F, et al. (1999). The effect of melatonin application on lipid peroxidation during cyclophosphamide therapy in female rats. Zentralbl Gynakol 121:499–502
  • Kern JC, Kehrer JP. (2002). Acrolein-induced cell death: A caspase-influenced decision between apoptosis and oncosis/necrosis. Chem Biol Interact 139:79–95
  • Kinnula VL, Crapo JD, Raivio KO. (1995). Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 73:3–19
  • Limper AH. (2004). Chemotherapy-induced lung disease. Clin Chest Med 25:53–64
  • Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–76
  • Lu J, Wu DM, Hu B, et al. (2010). Chronic administration of troxerutin protects mouse brain against d-galactose-induced impairment of cholinergic system. Neurobiol Learn Mem 93:157–64
  • Luck HA. (1963). Spectrophotometric method for estimation of catalase. In: Bergmeyer HV, ed. Methods of Enzymatic Analysis. New York: Academic Press, 886–8
  • Ludeman SM. (1999). The chemistry of the metabolites of cyclophosphamide. Curr Pharm Des 5:627–43
  • Man S, Zhang Y, Gao W, et al. (2008). Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma. Clin Exp Metastasis 25:855–64
  • Marklund S, Marklund G. (1974). Involvement of the superoxide anion radical in autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–74
  • Matés JM, Pérez-Gómez C, Núñez de Castro I. (1999). Antioxidant enzymes and human diseases. Clin Biochem 32:595–603
  • McCord JM, Fridovich I. (1969). Superoxide dismutase: An enzymatic function for erythrocuprein (hemoprotein). J Biol Chem 244:6049–55
  • Meotti FC, Stangherlin EC, Zeni G, et al. (2004). Protective role of aryl and alkyl diselenides on lipid peroxidation. Environ Res 94:276–82
  • Mythili Y, Sudharsan PT, Selvakumar E, Varalakshmi P. (2004). Protective effect of dl-alpha-lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem Biol Interact 151:13–19
  • Nogueira CW, Zeni G, Rocha JB. (2004). Organoselenium and organotellurium compounds: Toxicology and pharmacology. Chem Rev 104:6255–85
  • Okhawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Annal Biochem 95:351–8
  • Olivieri O, Girelli D, Stanzial AM, et al. (1996). Selenium, zinc, and thyroid hormones in healthy subjects: Low T3/T4 ratio in the elderly is related to impaired selenium status. Biol Trace Elem Res 51:31–41
  • Ozardali I, Bitiren M, Karakilçik AZ, et al. (2004). Effects of selenium on histopathological and enzymatic changes in experimental liver injury of rats. Exp Toxicol Pathol 56:59–64
  • Paglia DE, Valentine WN. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–69
  • Perera FP, Estabrook A, Hewer A, et al. (1995). Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4:233–8
  • Premkumar K, Pachiappan A, Abraham SK, et al. (2001). Effect of Spirulina fusiformis on cyclophosphamide and mitomycin-C induced genotoxicity and oxidative stress in mice. Fitoterapia 72:906–11
  • Rajasekaran NS, Devaraj H, Devaraj SN. (2002). The effect of glutathione monoester (GME) on glutathione (GSH) depleted rat liver. J Nutr Biochem 13:302–6
  • Rayman MP. (2000). The importance of selenium to human health. Lancet 356:233–41
  • Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. (2004). Nitric oxide in health and disease of the respiratory system. Physiol Rev 84:731–65
  • Richter C, Park JW, Ames BN. (1988). Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85:6465–7
  • Roy SS, Ghosh P, Sk UH, et al. (2010). Naphthalimide based novel organoselenocyanates: Finding less toxic forms of selenium that would retain protective efficacy. Bioorg Med Chem Lett 20:6951–5
  • Roy SS, Chakraborty P, Ghosh P, et al. (2012). Influence of novel naphthalimide-based organoselenium on genotoxicity induced by an alkylating agent: The role of reactive oxygen species and selenoenzymes. Redox Rep 17:157–66
  • Sayed-Ahmed MM, Eissa MA, Kenawy SA, et al. (2004). Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model. Chemotherapy 50:162–70
  • Sedlack J, Lindsay RN. (1968). Estimation of total protein bound and non-protein sulfhydryl groups in tissue with Ellman reagent. Annal Biochem 25:192–205
  • Senthilkumar S, Ebenezar KK, Sathish V, et al. (2006). Modulation of the tissue defense system by squalene in cyclophosphamide induced toxicity in rats. Arch Med Sci 2:94–100
  • Shinomol GK, Muralidhara. (2007). Differential induction of oxidative impairments in brain regions of male mice following sub chronic consumption of Khesari dhal (Lathyrus sativus) and detoxified Khesari dhal. Neurotoxicology 28:798–806
  • Siems W, Quast S, Carluccio F, et al. (2002). Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 58:S12–9
  • Singal PK, Petkau A, Gerrard JM, et al. (1988). Free radicals in health and disease. Mol Cell Biochem 84:121–2
  • Singh N, Dhalla AK, Seneviratne C, Singal PK. (1995). Oxidative stress and heart failure. Mol Cell Biochem 147:77–81
  • Sk UH, Sharma AK, Ghosh S, Bhattacharya S. (2010). Synthesis and biological evaluation of novel spiro 6-methoxytetralin-1,3′-pyrrolidine based organoselenocyanates against cadmium-induced oxidative and hepatic damage in mice. Eur J Med Chem 45:3265–73
  • Stadtman TC. (1991). Biosynthesis and function of selenocysteine-containing enzymes. J Biol Chem 266:16257–60
  • Sulkowska M, Skrzydlewska E, Sobaniec-Lotowska M, et al. (2002). Effect of cyclophosphamide-induced generation of oxygen forms on ultrastructure of liver and lung. Bull Vet Inst Pulawy 46:239–46
  • Tanaka T, Makita H, Kawabata K, et al. (1997). 1,4-Phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Cancer Res 57:3644–8
  • Tannehill SP, Mehta MP. (1996). Amifostine and radiation therapy: Past, present, and future. Semin Oncol 23:69–77
  • Uchida K, Shiraishi M, Naito Y, et al. (1999). Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274:2234–42
  • Yousefipour Z, Ranganna K, Newaz MA, Milton SG. (2005). Mechanism of acrolein-induced vascular toxicity. J Physiol Pharmacol 56:337–53
  • Zhang J, Tian Q, Zhou SF. (2006). Clinical pharmacology of cyclophosphamide and ifosfamide. Curr Drug Ther 1:55–84

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.